Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncogene

• Publication date

  2007-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1210156PMID 17160013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2007cited by this paper
• The Inhibition and Treatment of Breast Cancer with Poly (ADP-ribose) Polymerase (PARP-1) Inhibitors

  2006cited by this paper
• PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

  2006cited by this paper
• Genetic alteration of poly(ADP-ribose) polymerase-1 in human germ cell tumors

  2005cited by this paper
• Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent

  2005cited by this paper
• Genetic manipulation of mammary epithelium by transplantation

  2005cited by this paper
• Poly(ADP-ribose) Polymerase (PARP-1) in Homologous Recombination and as a Target for Cancer Therapy

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer.

  2005cited by this paper
• BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: An issue of potency

  2005cited by this paper
• Genetic alteration of poly(ADP-ribose) polymerase-1 in human germ cell tumors.

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

  2005cited by this paper
• Involvement of poly(ADP-ribose) polymerase 1 and poly(ADP-ribosyl)ation in regulation of centrosome function

  2004cited by this paper
• BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation.

  2004influential reference
• The PARP superfamily

  2004cited by this paper
• Identification of Genetic Variants in Base Excision Repair Pathway and Their Associations with Risk of Esophageal Squamous Cell Carcinoma

  2004cited by this paper
• The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function

  2004cited by this paper
• Parp‐1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane

  2003cited by this paper
• Involvement of Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribosyl)ation in Regulation of Centrosome Function

  2003cited by this paper
• Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice.

  2003cited by this paper
• Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.

  2003influential reference
• Poly(ADP‐ribose) and carcinogenesis

  2003cited by this paper
• Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation.

  2002influential reference
• Roles of BRCA1 in centrosome duplication

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Reduced poly(ADP‐ribosyl)ation in lymphocytes of laryngeal cancer patients: Results of a case‐control study

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis.

  2001cited by this paper
• Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice

  2001cited by this paper
• Inhibition of Poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice

  2001cited by this paper
• Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity.

  2001cited by this paper
• DNA Strand Break-Sensing Molecule Poly(ADP-Ribose) Polymerase Cooperates with p53 in Telomere Function, Chromosome Stability, and Tumor Suppression

  2001influential reference
• Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

  2001influential reference
• The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡

  2000cited by this paper
• Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage.

  2000cited by this paper
• Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

  2000cited by this paper
• A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.

  2000cited by this paper
• Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

  1999cited by this paper
• Mammary tumor formation in p53- and BRCA1-deficient mice.

  1999influential reference
• Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

  1999influential reference
• Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

  1999cited by this paper
• Failure of Poly(ADP-Ribose) Polymerase Cleavage by Caspases Leads to Induction of Necrosis and Enhanced Apoptosis

  1999cited by this paper
• p53 mutations in BRCA1-associated familial breast cancer.

  1998cited by this paper
• Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions

  1998cited by this paper
• Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis

  1997cited by this paper
• p53 mutations in BRCA1-associated familial breast cancer.

  1997cited by this paper
• Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis.

  1997cited by this paper
• Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer.

  1996cited by this paper
• Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

  1995cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper

• PARP-1 negatively regulates nucleolar protein pool and mitochondrial activity: a cell protective mechanism

  2024cites this paper
• Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones

  2022cites this paper
• Defective DNA polymerase beta invoke a cytosolic DNA mediated inflammatory response

  2022cites this paper
• PARP1 rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis

  2021cites this paper
• PARP1 rs1136410 (A/G) polymorphism is associated with early age of onset of gallbladder cancer

  2021cites this paper
• New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy

  2020cites this paper
• The Cell Cycle, Cytoskeleton and Cancer

  2019cites this paper
• BCL10 in cell survival after DNA damage.

  2019cites this paper
• The Use of Radioprotective Agents to Prevent Effects Associated with Aging

  2019cites this paper
• A brief review on chemical agents involved in chromosomal aberrations in military wars

  2019cites this paper
• Mitotic functions of poly(ADP-ribose) polymerases

  2019cites this paper
• PARP1 gene polymorphisms and neuroblastoma susceptibility in Chinese children

  2019cites this paper
• An Interaction with PARP-1 and Inhibition of Parylation Contribute to Attenuation of DNA Damage Signaling by the Adenovirus E4orf4 Protein

  2019cites this paper
• PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.

  2018cites this paper
• Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

  2018cites this paper
• Oncogenic activity of poly (ADP-ribose) glycohydrolase

  2018cites this paper
• A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy

  2018cites this paper
• The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1

  2017cites this paper
• ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.

  2017cites this paper
• Dividing with Extra Centrosomes: A Double Edged Sword for Cancer Cells.

  2017cites this paper
• 17 BRCA 2 Mutations and Consequences for DNA Repair

  2017cites this paper
• The Role of Hsp70 and Nek6 in Centrosome Clustering in Cancer Cells

  2017cites this paper
• PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

  2016cites this paper
• Trial watch – inhibiting PARP enzymes for anticancer therapy

  2016cites this paper
• New Facets in the Regulation of Gene Expression by ADP-Ribosylation and Poly(ADP-ribose) Polymerases

  2015cites this paper
• PARP and Carcinogenesis

  2015cites this paper
• Inhibition of Centrosome Amplification in Human Osteosarcoma Cells (Saos2) by Antioxidants Glutathione and

  2015cites this paper
• Regulation of Ribosomal Gene Expression in Cancer

  2015cites this paper
• PARP Enzymes are Potential Targets for Cancer Chemotherapy

  2015cites this paper
• Multitasking Roles for Poly(ADP-ribosyl)ation in Aging and Longevity

  2015cites this paper
• Role of PARP2 in DNA repair

  2014cites this paper
• Mustard gas surrogate, 2-chloroethyl ethylsulfide (2-CEES), induces centrosome amplification and aneuploidy in human and mouse cells

  2014cites this paper
• The role of thiamine in cancer: possible genetic and cellular signaling mechanisms.

  2013cites this paper
• Beyond DNA Repair: Additional Functions of PARP-1 in Cancer

  2013cites this paper
• A novel class of substituted spiro [quinazoline-2,1'-cyclohexane] derivatives as effective PPAR-1 inhibitors: molecular modeling, synthesis, cytotoxic and enzyme assay evaluation.

  2013cites this paper
• Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population

  2013cites this paper
• Clinical and Molecular Significance of Poly (ADP-Ribose) Polymerase-1 (PARP-1) in Breast Cancer of African Women and its Potential as a Targeted Therapy

  2013cites this paper
• PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets

  2013cites this paper
• Metabolic modulation of chromatin: implications for DNA repair and genomic integrity

  2013cites this paper
• Poly(ADP-ribosyl)ation in carcinogenesis.

  2013cites this paper
• Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors.

  2013cites this paper
• DNA Damage Repair Pathways and Synthetic Lethality

  2013cites this paper
• The potential of the PARP-1 inhibitor, AGO14699, in human cancers defective in homologous recombination DNA repair

  2012cites this paper
• Pleiotropic Cellular Functions of PARP1 in Longevity and Aging: Genome Maintenance Meets Inflammation

  2012cites this paper
• Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy

  2012cites this paper
• Functional Aspects of PARP1 in DNA Repair and Transcription

  2012cites this paper
• Exploiting synthetic lethal interactions between DNA damage signaling, checkpoint control, and p53 for targeted cancer therapy.

  2012cites this paper
• The role of PARP1 in the DNA damage response and its application in tumor therapy

  2012cites this paper
• The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms

  2012cites this paper
• PARP1 expression in breast cancer and effects of its inhibition in preclinical models

  2012cites this paper
• The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms

  2012cites this paper
• Targeting PARP-1 in Breast Cancer: Th e Paradigm of a DNA Repair-based Th erapeutic Strategy

  2012cites this paper
• Allelic variants of polymorphic genes associated with a higher frequency of chromosome aberrations

  2011cites this paper
• PARP Inhibitors

  2011cites this paper
• Establishment of primary mouse lung adenocarcinoma cell culture.

  2011cites this paper
• BRCA2 Mutations and Consequences for DNA Repair

  2011cites this paper
• PARP-1 and PARP-2: New players in tumour development.

  2011cites this paper
• PARP INHIBITORS IN ONCOLOGY: A NEW SYNTHETIC LETHAL APPROACH TO CANCER THERAPY

  2011cites this paper
• Poly(ADP‐Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

  2011cites this paper
• Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges

  2011cites this paper
• A review of PARP inhibitors: from bench to bedside.

  2011cites this paper
• Frameshift mutations of poly(adenosine diphosphate-ribose) polymerase genes in gastric and colorectal cancers with microsatellite instability.

  2011cites this paper
• The emerging role of poly(ADP-Ribose) polymerase inhibitors in cancer treatment.

  2011cites this paper
• Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.

  2010cites this paper
• Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice

  2010cites this paper
• The use of PARP inhibitors in the prophylaxis and treatment of breast cancer in BRCA1 deficient.

  2010cites this paper
• Inducing synthetic lethality using PARP inhibitors.

  2010cites this paper
• The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer

  2010cites this paper
• Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.

  2010cites this paper
• PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

  2009cites this paper
• Exploiting synthetic lethal interactions for targeted cancer therapy

  2009cites this paper
• Development of PARP inhibitors in oncology

  2009cites this paper
• PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

  2009cites this paper
• Modulatory effects of α- and γ-tocopherols on 4-hydroxyestradiol induced oxidative stresses in MCF-10A breast epithelial cells

  2009cites this paper
• Development of PARP inhibitors in oncology.

  2009cites this paper
• The expanding field of poly(ADP-ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects' Review Series

  2008influential citation
• Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity.

  2008cites this paper
• DNA repair deficiency as a therapeutic target in cancer.

  2008cites this paper
• PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma.

  2008cites this paper
• Targeted therapy for cancer using PARP inhibitors.

  2008cites this paper
• Bacterial DNA repair genes and their eukaryotic homologues: 1. Mutations in genes involved in base excision repair (BER) and DNA-end processors and their implication in mutagenesis and human disease.

  2007cites this paper
• Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients.

  2007cites this paper
• Mammary cancer susceptibility: human genes and rodent models

  2007cites this paper
• Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.

  2007cites this paper
• Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer

  2007cites this paper
• Tumorigenesis: Jagged little pill?

  2007cites this paper
• Exploiting Synthetic Lethal Interactions for Targeted Cancer Therapy Accessed Terms of Use Detailed Terms

  year unknowncites this paper